120 related articles for article (PubMed ID: 10468961)
1. Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity.
Christ ER; Chowienczyk PJ; Sönksen PH; Russel-Jones DL
Clin Endocrinol (Oxf); 1999 Jul; 51(1):21-5. PubMed ID: 10468961
[TBL] [Abstract][Full Text] [Related]
2. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.
Christ ER; Cummings MH; Lumb PJ; Crook MA; Sönksen PH; Russell-Jones DL
Clin Endocrinol (Oxf); 1999 Aug; 51(2):173-9. PubMed ID: 10468987
[TBL] [Abstract][Full Text] [Related]
4. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.
Evans LM; Davies JS; Anderson RA; Ellis GR; Jackson SK; Lewis MJ; Frenneaux MP; Rees A; Scanlon MF
Eur J Endocrinol; 2000 Mar; 142(3):254-62. PubMed ID: 10700719
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
Evans LM; Davies JS; Goodfellow J; Rees JA; Scanlon MF
Clin Endocrinol (Oxf); 1999 Apr; 50(4):457-64. PubMed ID: 10468904
[TBL] [Abstract][Full Text] [Related]
6. Abnormal vascular reactivity in growth hormone deficiency.
Capaldo B; Guardasole V; Pardo F; Matarazzo M; Di Rella F; Numis F; Merola B; Longobardi S; Saccà L
Circulation; 2001 Jan; 103(4):520-4. PubMed ID: 11157716
[TBL] [Abstract][Full Text] [Related]
7. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency.
McCallum RW; Sainsbury CA; Spiers A; Dominiczak AF; Petrie JR; Sattar N; Connell JM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):473-9. PubMed ID: 15807879
[TBL] [Abstract][Full Text] [Related]
9. Does lipoprotein(a) impair endothelial function?
Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
[TBL] [Abstract][Full Text] [Related]
10. Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy.
Hayes FJ; Fiad TM; McKenna TJ
Metabolism; 1999 Mar; 48(3):308-13. PubMed ID: 10094105
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of growth hormone on vascular function in human subjects.
Napoli R; Guardasole V; Angelini V; D'Amico F; Zarra E; Matarazzo M; Saccà L
J Clin Endocrinol Metab; 2003 Jun; 88(6):2817-20. PubMed ID: 12788893
[TBL] [Abstract][Full Text] [Related]
12. The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency.
Christ ER; Simpson HL; Breen L; Sönksen PH; Russell-Jones DL; Kohner EM
Clin Endocrinol (Oxf); 2003 Mar; 58(3):309-15. PubMed ID: 12608936
[TBL] [Abstract][Full Text] [Related]
13. The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real-life data from the NordiNet
Weber MM; Biller BM; Pedersen BT; Pournara E; Christiansen JS; Höybye C
Clin Endocrinol (Oxf); 2017 Feb; 86(2):192-198. PubMed ID: 27736009
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone replacement therapy on plasma diacron-reactive oxygen metabolites and endothelial function in Japanese patients: The GREAT clinical study.
Suzuki K; Yanagi K; Shimizu M; Wakamatsu S; Niitani T; Hosonuma S; Sagara M; Aso Y
Endocr J; 2018 Jan; 65(1):101-111. PubMed ID: 29070768
[TBL] [Abstract][Full Text] [Related]
15. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
16. Endothelial function and common carotid artery wall thickening in patients with essential hypertension.
Ghiadoni L; Taddei S; Virdis A; Sudano I; Di Legge V; Meola M; Di Venanzio L; Salvetti A
Hypertension; 1998 Jul; 32(1):25-32. PubMed ID: 9674633
[TBL] [Abstract][Full Text] [Related]
17. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
18. Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement.
Hána V; Prázný M; Marek J; Skrha J; Justová V
Eur J Endocrinol; 2002 Sep; 147(3):333-7. PubMed ID: 12213670
[TBL] [Abstract][Full Text] [Related]
19. Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk.
Abdu TA; Elhadd TA; Buch H; Barton D; Neary R; Clayton RN
Clin Endocrinol (Oxf); 2004 Sep; 61(3):387-93. PubMed ID: 15355457
[TBL] [Abstract][Full Text] [Related]
20. Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients.
Avogaro A; Piarulli F; Valerio A; Miola M; Calveri M; Pavan P; Vicini P; Cobelli C; Tiengo A; Calò L; Del Prato S
Diabetes; 1997 Jun; 46(6):1040-6. PubMed ID: 9166677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
